fondaparinux

(redirected from Arixtra)
Also found in: Medical.
Translations

fondaparinux

n fondaparinux m
References in periodicals archive ?
Fondaparinux is a generic version of the anticoagulant drag Arixtra.
Arixtra is approved in the US and Europe for the treatment of deep vein thrombosis and pulmonary embolism and is also indicated for the prevention of DVT after major surgery, such as knee and hip replacement.
Reddy's Laboratories stated that Fondaparinux is a generic version of the anticoagulant drug Arixtra, which is approved in the US and Europe for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
5 mL; Arixtra, GlaxoSmithKline, Greenford, United Kingdom), enoxaparin (10 000 anti-Xa IU/mL; Clexane, Sanofi Aventis, Budapest, Hungary) and danaparoid solution (750 anti-Xa IU/0.
Reddy's ANDA for Fondaparinux Sodium Injection, a bioequivalent generic version of Arixtra, in the US market by the United States Food and Drug Administration (USFDA).
Investigators in the study, known as the Comparison of Arixtra in Lower Limb Superficial Vein Thrombosis with Placebo (CALISTO) trial, compared the efficacy and safety of the specific factor Xa inhibitor fondaparinux with placebo in reducing symptomatic venous thromboembolic complications or death from any cause.
This follows the news that the pharmaceutical giant has gained EU approval on its anti-clotting drug, Arixtra.
Initially approved in the US in December 2001, the agent is currently marketed in 30 countries worldwide under the trade name of Arixtra.
Heparins and heparinoids (used in the treatment of thromboses): to sell all of its development, production and marketing activities relating to Fraxiparine and Arixtra at world level.
The group yesterday struck a deal with Sanofi-Synthelabo to buy injectable drugs Fraxiparine and Arixtra, which have combined annual sales of 343 million euros (pounds 225.
There is a synthetic alternative called Arixtra but, although it has been approved for prescription, it is not available in all parts of Wales.